首页> 美国卫生研究院文献>BMC Veterinary Research >Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice
【2h】

Prostaglandin E2 secreted from feline adipose tissue-derived mesenchymal stem cells alleviate DSS-induced colitis by increasing regulatory T cells in mice

机译:猫脂肪组织间充质干细胞分泌的前列腺素E2通过增加小鼠的调节性T细胞缓解DSS诱导的结肠炎

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInflammatory bowel disease (IBD) is an intractable autoimmune disease, relatively common in cats, with chronic vomiting and diarrhea. Previous studies have reported that mesenchymal stem cells (MSCs) alleviate inflammation by modulating immune cells. However, there is a lack of research on cross-talk mechanism between feline adipose tissue-derived mesenchymal stem cells (fAT-MSCs) and immune cells in IBD model. Hence, this study aimed to evaluate the therapeutic effects of fAT-MSC on mice model of colitis and to clarify the therapeutic mechanism of fAT-MSCs.
机译:背景炎症性肠病(IBD)是一种顽固的自身免疫病,在猫中相对常见,伴有慢性呕吐和腹泻。先前的研究报道了间充质干细胞(MSCs)通过调节免疫细胞来减轻炎症。然而,在IBD模型中,关于猫脂肪组织间充质干细胞(fAT-MSC)与免疫细胞之间的串扰机制缺乏研究。因此,本研究旨在评估fAT-MSC对结肠炎小鼠模型的治疗效果,并阐明fAT-MSC的治疗机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号